Insights - Novavax (NVAX) had their Q2 business update call yesterday after market. The company announced yet another delay in the US submission, while the rest of the world’s … Continue Reading
Premium: Read NowInsights - Jounce (JNCE) announced 2Q results today and the company is progressing well on their Phase 1 JTX-8064 (LILRB2 / ILT4) in solid tumors. Jounce completed enrollment of … Continue Reading
Premium: Read NowInsights - The Covid delta variant is making waves, and several countries are voicing concern. Below we look at the data and determine if the high alert … Continue Reading
Premium: Read NowInsights - Magenta announced that the FDA has placed a clinical hold on their IND filed in June 2021 for conditioning agent MGTA-117. As a result, MGTA will need … Continue Reading
Premium: Read NowInsights - Yesterday, Eloxx (ELOX) was down 17% to $1.60 after the company provided an enrolment update for ELX-02 Phase 2 in cystic fibrosis. The company expects to present … Continue Reading
Premium: Read NowInsights - Affimed had the Q1 business update call this morning. The call was not well received after the company did not shed much light on AFM24 progress and … Continue Reading
Premium: Read NowInsights - Last week, Jounce hosted their R&D day to update investors on their pipeline and future prospects (watch webinar here). Overall, we thought the company provided good … Continue Reading
Premium: Read Now
